2nd Quarter - Report

ALERE INC. for ALERE INC.

Period 2nd Quarter 2012 Filed Jul 20, 2012 Signed by Seth M. Radus, VP, Government Affairs

Official filing
Firm
ALERE INC.
Client
ALERE INC.
Income
—
Expenses
$156,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare payment for clinical diagnostic laboratory tests Medicare coverage of clinical diagnostic laboratory tests

LobbyistCovered position, as disclosed
SETH M RADUS —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Health Issues HCR

FDA regulation of clinical laboratory tests (S. 3187, Food and Drug Administration Innovation and Safety Act) The Generating Antibiotics Incentives Now Act (H.R. 2182, S. 1734) FDA regulation of prescription drugs

LobbyistCovered position, as disclosed
SETH M RADUS —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1734 (112th), H.R. 2182 (112th), S. 3187 (112th)

Medical/Disease Research/Clinical Labs MED

Development of new and innovative in-vitro diagnostic tests.

LobbyistCovered position, as disclosed
SETH M RADUS —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.